JNTU Pharm. D IV Year BIOSTATISTICS AND RESEARCH METHODOLOGY Previous Question Paper (April/May - 2019 - R08)

Interventional studies, or clinical trials, are prospective studies where the researcher actively intervenes by assigning participants to specific groups (e.g., treatment vs. control) to evaluate the efficacy and safety of a medical intervention. The gold standard is the Randomized Controlled Trial (RCT). Key design features include randomization to eliminate selection bias, blinding (single, double, or triple) to prevent observer and participant bias, and the use of a control group (placebo or standard care) for comparison. These studies are essential for establishing causal relationships between an intervention and a clinical outcome.

Sample size determination is the process of calculating the minimum number of participants required to detect a clinically meaningful effect with statistical significance. It is calculated based on four primary parameters: Alpha (α) (significance level, usually 0.05), Beta (β) (Type II error rate), the Effect Size (the magnitude of difference expected), and the Standard Deviation of the outcome variable. An inadequate sample size leads to underpowered studies that may fail to detect true effects, while an excessively large sample size wastes resources and may expose more participants than necessary to experimental conditions.